美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HORIZON KINETICS MEDICAL ETF

34.96

-0.3314-0.94%

成交量：588

成交額：2.06萬

市值：1,642.82萬

市盈率：- -

高：35.04

開：34.99

低：34.96

收：35.29

52周最高：37.90

52周最低：28.87

股本：46.99萬

流通股本：46.99萬

量比：0.27

換手率：0.13%

股息：0.41

股息率：1.17%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

從美妝到生物科技公司植物醫生挺進大健康領域

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

創新藥概念震盪反彈德展健康3天2板

港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)

百利天恒：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

國內首款AI輔助創新藥獲批上市！西湖大學聯合研發僅用時三年半

我國首款AI輔助創新藥獲批上市

創新藥三大指數上漲、ETF吸金，CXO及科研服務呈高景氣度

海南出台醫療器械委託生產監管新政

創新藥投資，優先佈局這些可把握的機會

证券市场周刊

格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械

2026年國家醫保目錄現場談判競價與商保創新藥目錄價格協商在京開啓

研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方

中國中藥(00570)：1.1類中藥創新藥醒脾解鬱片獲批上市

中國中藥：同濟堂製藥1.1類中藥創新藥醒脾解鬱片獲批上市

服務退役軍人有成效，貴州企業獲國家級授牌！

重大臨床突破引爆，康方生物單日飆漲11.45%！港股通創新藥量價齊升，新一輪行情啓動？

聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥

復旦張江：公司將於9月16日參加2026年半年度科創板創新藥行業集體業績説明會

廣州金堃醫學檢驗實驗室有限公司成立

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/MEDX/news?page=11"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MEDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","market":"US","secType":"STK","nameCN":"HORIZON KINETICS MEDICAL ETF","latestPrice":34.9577,"timestamp":1789502400000,"preClose":35.2891,"halted":0,"volume":588,"delay":0,"changeRate":-0.009391001754082565,"floatShares":469946,"shares":469946,"eps":0,"marketStatus":"盤前交易","change":-0.3314,"latestTime":"09-16 07:02:08 EDT","open":34.99,"high":35.04,"low":34.9577,"amount":20606,"amplitude":0.002332,"askPrice":37,"askSize":35,"bidPrice":34.05,"bidSize":15,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.9577,"sharesOutstanding":569946,"nav":35.26,"aum":16570295.96,"dividendRate":0.0117,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.04,"preClose":34.9577,"latestTime":"16:10 EDT","volume":6,"amount":209.6308,"timestamp":1789503007392,"change":0.0823,"changeRate":0.002354,"amplitude":0},"volumeRatio":0.2679303977521077},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MEDX\",,,,,undefined,":{"symbol":"MEDX","floatShares":469946,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2679303977521077,"shares":469946,"dividePrice":0.409,"high":35.04,"amplitude":0.002332,"preClose":35.2891,"low":34.9577,"week52Low":28.8652,"pbRate":"--","week52High":37.9,"institutionHeld":0,"latestPrice":34.9577,"committee":-0.4,"eps":0,"divideRate":0.0117,"volume":588,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":33.2024,"prevWeekClose":34.9572,"prevMonthClose":36.417,"prevQuarterClose":36.7138,"fiveDayClose":35.4213,"twentyDayClose":35.8903,"sixtyDayClose":33.8763},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MEDX\",params:#limit:5,,,undefined,":[{"date":"2025-12-23","symbol":"MEDX","amount":0.4088,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-24"},{"date":"2024-12-24","symbol":"MEDX","amount":0.502335,"announcedDate":"2024-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-24","defaultRemindTime":1735050600000,"name":"HORIZON KINETICS MEDICAL ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-24","currency":"USD","dateTimestamp":1735016400000,"payDate":"2024-12-26"},{"date":"2023-12-27","symbol":"MEDX","amount":1.379798,"announcedDate":"2023-12-26","type":"dividend","market":"US","newRecordDate":"2023-12-28","defaultRemindTime":1703687400000,"name":"HORIZON KINETICS MEDICAL ETF","recordDate":"2023-12-29","payableDate":"2023-12-28","currency":"USD","dateTimestamp":1703653200000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MEDX\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":1.379798,"currency":"USD"},{"executeDate":"2024-12-24","recordDate":"2024-12-24","paymentDate":"2024-12-26","value":0.502335,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-24","value":0.4088,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MEDX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MEDX\",pageSize:20,pageCount:11,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665962333","title":"從美妝到生物科技公司 植物醫生挺進大健康領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2665962333","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665962333?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:46","pubTimestamp":1788752760,"startTime":"0","endTime":"0","summary":"渠道红利退去、流量成本攀升、产品同质化加剧……中国美妆行业正经历从“快车道”到“窄门”的残酷转型。当“一招鲜”的战术红利消失，建立底层技术壁垒不再是可选项，而是生存项。当全行业 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260907/c679648733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["159837","LNGR","BK4588","GDOC","HBImain","XBI","BK4581","MEDX","IBBJ","BK4585","SYNB","AGNG","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PTH","BK1100","HART","LNGR","MDEV","BK4127","LGHT","GDOC","AGNG","RSPH","09996","IEIH","BK1574","BK1583","FRHC","159883","IPOS","REDS","MEDX","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665895395","title":"創新藥概念震盪反彈 德展健康3天2板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665895395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665895395?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:15","pubTimestamp":1788747304,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665836774","title":"港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665836774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665836774?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 06:53","pubTimestamp":1788735233,"startTime":"0","endTime":"0","summary":"西湖大学生命科学学院教授黄晶表示，AI辅助新药研发已不止于概念，而真正可以支撑原创药物从发现走向临床，直至上市。艾普司韦是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。中国AI制药市场规模2025年已突破6亿元。从经营数据来看，AI相关业务正成为部分企业订单和收入增长的重要驱动力；与此同时，下游药企也在积极拥抱AI，研发提效成果逐步显现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","VTHR","VXUS","BK1161","BK1574","02196","IBBQ","03696","BK1617","BK1141","LNGR","BK1593","02228","MEDX","KCAI","159992","AIPO","BK1191","ARTY","AGIX","BK4585","BK1515","QTOC","CHAT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665709364","title":"百利天恒：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665709364","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665709364?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:31","pubTimestamp":1788690660,"startTime":"0","endTime":"0","summary":"证券日报网讯9月6日，百利天恒发布公告称，公司计划于2026年9月16日15：00-17：00参加科创板2026年半年度创新药行业集体业绩说明会，就投资者关心的问题进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-06/doc-iniqwwyu6754784.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-06/doc-iniqwwyu6754784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","IBBQ","BK0239","MEDX","KSTR","91194","LNGR","BK1161","688506","BK1574","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665403361","title":"國內首款AI輔助創新藥獲批上市！西湖大學聯合研發 僅用時三年半","url":"https://stock-news.laohu8.com/highlight/detail?id=2665403361","media":"快科技","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665403361?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:30","pubTimestamp":1788679839,"startTime":"0","endTime":"0","summary":"快科技9月6日消息，据西湖大学微信公众号消息，近期，由西湖大学、西湖实验室、西湖制药联合研发的创新药——盐酸伊司特韦片 正式获得国家药品监督管理局附条件批准上市。据悉，它是国内首款凭借AI辅助研发而获批上市的原创药——从源头发现到完成临床试验，仅用时三年半。这也是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8wCSabf9QIo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["IBBQ","ARTY","AIPO","AGIX","BK1161","06978","MEDX","159992","BK1574","VTHR","IPOS","CHAT","QTOC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361592","title":"我國首款AI輔助創新藥獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361592?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:04","pubTimestamp":1788678281,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","IPOS","AGIX","IBBQ","ARTY","QTOC","LNGR","VTHR","AIPO","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665369630","title":"創新藥三大指數上漲、ETF吸金，CXO及科研服務呈高景氣度","url":"https://stock-news.laohu8.com/highlight/detail?id=2665369630","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665369630?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 09:57","pubTimestamp":1788659820,"startTime":"0","endTime":"0","summary":"H股创新药指数2026上半年收入同比增长17.91%、归母净利润同比增长60.94%、扣非归母净利润同比增长30.73%。银河证券分析称，上半年行业利润增长显著快于收入，主要系创新药商业化收入及对外授权收入增加，高毛利业务占比大幅提升，同时CXO和科研服务呈高景气度，订单增长驱动前期产能建设和人员储备充分利用，摊薄固定成本并推动利润增长。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-06/doc-iniqvzvc0193188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CXO","FDN","BK4550","BK1574","WX","MEDX","BK4588","BK1161","BK4585","LNGR","159992","06978","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665250366","title":"海南出台醫療器械委託生產監管新政","url":"https://stock-news.laohu8.com/highlight/detail?id=2665250366","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665250366?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 07:43","pubTimestamp":1788651815,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","LGHT","IEIH","PTH","MEDX","GDOC","AGNG","HART","RSPH","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665538368","title":"創新藥投資，優先佈局這些可把握的機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2665538368","media":"证券市场周刊","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665538368?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:51","pubTimestamp":1788591110,"startTime":"0","endTime":"0","summary":"当AI行情阶段性休整、市场四处寻找下一条主线之时，创新药板块悄然走出一轮反弹行情。Wind数据显示，2026年6月9日至9月2日，恒生沪深港创新药50指数涨幅达到33.08%，CXO指数涨幅46.07%。但赛道本身波动性也极强。2025年前三季度，部分创新药指数最高涨幅超100%，随后自去年10月开启长达8个月的深度调整，截至2026年5月底，板块最大回撤超过30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609053866007987.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609053866007987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","MEDX","LNGR","IBBQ","06978","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665350040","title":"格式塔創始人彭雷：三到五年內，腦機接口本質上是嚴肅的醫療器械","url":"https://stock-news.laohu8.com/highlight/detail?id=2665350040","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665350040?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 14:01","pubTimestamp":1788588060,"startTime":"0","endTime":"0","summary":"格式塔创始人、CEO彭雷表示，脑机接口赛道要解决的核心问题就一个：持续提高对脑内读写的分辨率。在他看来，至少在看得见的三到五年内，脑机接口本质上还是严肃的医疗器械，它的创新落地，付费方一定是医疗体系与患者。他指出，如何依托我国特色的医疗保障体系，让前沿的脑机接口应用纳入医保，惠及更多患者、解决实际病痛，这就是付费层面需要思考的问题。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-09-05/doc-iniquccw0443893.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LNGR","RSPH","09996","BK1583","BK1574","MNTL","159883","GDOC","HART","IEIH","MEDX","LGHT","MDEV","AGNG","PTH","BK1100","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352256","title":"2026年國家醫保目錄現場談判競價與商保創新藥目錄價格協商在京開啓","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352256","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352256?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 08:12","pubTimestamp":1788567172,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665561483","title":"研究發現，美國越來越多的12歲以下兒童被開具減肥藥處方","url":"https://stock-news.laohu8.com/highlight/detail?id=2665561483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665561483?lang=zh_tw&edition=fundamental","pubTime":"2026-09-05 02:45","pubTimestamp":1788547556,"startTime":"0","endTime":"0","summary":"研究发现，美国越来越多的12岁以下儿童被开具减肥药处方路透9月4日-据周五发表的一项研究显示，由于医生们正在为患有肥胖症的年轻患者寻求新的有效治疗方法，自2019年以来，美国12岁以下儿童的GLP-1减肥药处方量已增长了300多倍。该研究涵盖了350多万名8至11岁、患有肥胖症但未患糖尿病的儿童，结果显示GLP-1减肥药的处方率从2019年的0.03%上升至截至6月的9.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4T44W18V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1127390331.HKD","SG9999013999.USD","LU1366192091.USD","LU2063271972.USD","LU2112291526.USD","BK4599","IE00BK4W5L77.USD","LU2750360997.AUD","SG9999018865.SGD","IE00BJJMRZ35.SGD","LU0708995401.HKD","LU1280957306.USD","ELIS","LU2023250504.SGD","LU1868836591.USD","LU1979441026.SGD","LU0079474960.USD","LLYZ","LU0203202063.USD","LU0256863902.USD","LU1064131342.USD","LU1988902786.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU1323610961.USD","BK4581","LU2237443978.SGD","IE0004445015.USD","LU0683600562.USD","FHLC","LU2168564495.EUR","LU1551013425.SGD","LU2361044865.SGD","MEDX","LU2324357040.USD","MHIP","LU2237443465.HKD","BK4516","GB00BDT5M118.USD","IE0004445239.USD","LU1712237335.SGD","LU0133085943.USD","LU1720051108.HKD","SG9999014906.USD","LU2491050071.SGD","SGXZ57979304.SGD","RXL","LLY","IE0002141913.USD","BK4534","LU0882574055.USD","IE00BJLML261.HKD","LU2361045086.USD","LU2756315318.SGD","ELIL","LU0210536198.USD","LU2237443895.HKD","LU1145028129.USD","LU2237443382.USD","LU1267930730.SGD","LU2462591350.SGD","XLV","LU2108987350.USD","CURE","NVOC","OZEM","LU2211815571.USD","IE00BKPKM429.USD","LU2168564065.EUR","LU2089984988.USD","LU1974910355.USD","GDOC","LU2746668461.USD","LU2271345857.HKD","IHE","LU1804176565.USD","LU2023250330.USD","LU0174119429.USD","SG9999017495.SGD","LU0471298777.SGD","LU2168564149.EUR","TMED","LU1551013342.USD","LU0158827948.USD","BK4007","VHT","LU0266013472.USD","LU0006306889.USD","SG9999001176.USD","SG9999014880.SGD","LU0114720955.EUR","LU0417517546.SGD","LU1232071149.USD","LU2213496289.HKD","SGXZ31699556.SGD","LU0471298694.HKD","JDOC","SG9999015986.USD","IE00BJJMRY28.SGD","MEDI","NVOH","LU0456855351.SGD","LU0820561909.HKD","LU2028103732.USD","LU0889565916.HKD","SG9999014914.USD","SGXZ51526630.SGD","LU0820562030.AUD","LU2468319806.SGD","LU2471134952.CNY","LU2236285917.USD","IYH","LU0158827781.USD","LU0320765059.SGD","PJP","LU2750360641.GBP","LU1023059063.AUD","LU1989771016.USD","LU2168564222.USD","IE00BN29S564.USD","LU1093756168.USD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","THNR","SGXZ81514606.USD","LU0234572021.USD","SG9999015978.USD","LU2089284900.SGD","LLII","IE00B1XK9C88.USD","LU1691799644.USD","LU0353189763.USD","LU1061106388.HKD","IE00BWXC8680.SGD","LU2417539215.USD","NVO","LU1868837136.USD","IE00BFSS8Q28.SGD","LU0353189680.USD","LLYX","LU0122379950.USD","LU2756315664.SGD","IE00BFSS7M15.SGD","IE00BZ1G4Q59.USD","LU1548497426.USD","SG9999014898.SGD","BK4585","IE0001KFT4U8.USD","LU0354030438.USD","LU0786609619.USD","LU1814569148.SGD","LU2552382215.SGD","LU2491050154.USD","LU0316494557.USD","LU0823434583.USD","BK4532","CANC","LU1069344957.HKD","LU2168563687.JPY","LU0097036916.USD","NVOX","IE00B4JS1V06.HKD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU2462157665.USD","LU0640476718.USD","LU0432979614.USD","WDNA","LU0154236417.USD","LU2237443622.USD","SGXZ99366536.SGD","LU1868837300.USD","LU1093756325.SGD","LU0094547139.USD","LU0109394709.USD","LU2023251221.USD","LU2552382132.HKD","SG9999015952.SGD","LU0823434740.USD","LU2237443549.SGD","LU0289739699.SGD","LU1720051017.SGD","LU0466842654.USD","LU0964807845.USD","LU0943347566.SGD","LU1868836757.USD","LU0238689110.USD","LU0320765992.SGD","LU0096364046.USD","LU0354030511.USD","LU0672654240.SGD","LU2361044949.HKD","IE0005OL40V9.USD","LU2357305700.SGD","LU2456880835.USD","LU0323591593.USD","LU0106261372.USD","LU2089283258.USD","IE00B1BXHZ80.USD","BK4588","FTXH","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU0689472784.USD","LU2491049909.HKD","PPH","IXJ","LU0820561818.USD","LU2265009873.SGD","LU2461242641.AUD","LU1035775433.USD","IE00BK4W5M84.HKD","LU0225283273.USD","LU1917777945.USD","TRUH","LU0058720904.USD","LU1057294990.SGD","LU2106854487.HKD","AGNG","LU1868836914.USD","LU2552382058.USD","LU1983299246.USD","SG9999001176.SGD","LU1623119135.USD","LU2602419157.SGD","IE00B775H168.HKD","LU0198837287.USD","LU2111349929.HKD","BK4533","IE00BJT1NW94.SGD","LU0061475181.USD","IE00B2B36J28.USD","LU2471134523.USD","LU2471134879.HKD","LU0109391861.USD","LU0823416689.USD","LU0787776722.HKD","LU1629891620.HKD","LU0345770993.USD","LU2087625088.SGD","SG9999018857.SGD","LU2746668974.SGD","IE0009355771.USD","LU0256863811.USD","SG9999015945.SGD","LU2237438978.USD","LU2360106947.USD","ILDR","LU1291159041.SGD","LU2896262040.SGD","LU0345770308.USD","HRTS","LU0203201768.USD","LU2471134796.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334496","title":"中國中藥(00570)：1.1類中藥創新藥醒脾解鬱片獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334496","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334496?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:50","pubTimestamp":1788526251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国中药(00570)发布公告，有关国家药监局受理集团的附属公司国药集团同济堂（贵州）制药有限公司（同济堂制药）的1.1类中药创新药郁枢达片注册上市申请。经国家药监局完成技术审评、现场核查、抽样检验等一系列工作程序，同济堂制药申报的1.1类中药创新药醒脾解郁片（即先前公告所称“郁枢达片”，为该药品获国家药监局核准的规范通用名称）已获得批准上市，药品上市许可持有人为同济堂制药。醒脾解郁片具有醒脾化湿、理气解郁的功效，用于轻、中度抑郁症，症状为情绪郁闷、低落，表情淡漠、倦怠乏力、失眠多梦、少气懒言、食少纳呆，头重肢困、 口中黏腻、面色晦暗，舌淡苔白腻或灰腻、脉滑或弦。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00570","IPOS","06978","159992","BK1574","BK1515","IBBQ","BK1606","BK1161","MEDX","BK1191","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334139","title":"中國中藥：同濟堂製藥1.1類中藥創新藥醒脾解鬱片獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334139","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334139?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 20:48","pubTimestamp":1788526108,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LNGR","IBBQ","IPOS","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664633992","title":"服務退役軍人有成效，貴州企業獲國家級授牌！","url":"https://stock-news.laohu8.com/highlight/detail?id=2664633992","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664633992?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:20","pubTimestamp":1788520800,"startTime":"0","endTime":"0","summary":"9月3日，中国退役军人就业创业服务促进会授牌仪式在贵阳举行。贵州省松平生物科技有限公司被授予“中国退役军人就业创业服务促进会副理事长单位”会员。据了解，贵州省松平生物科技有限公司为退役军人创办，主业聚焦生物制药、健康保健和职业培训。此次授牌，标志着该企业正式纳入全国退役军人就业创业服务体系，将获得促进会在资源对接、政策指导、人才培育、创业帮扶等多方面的专业支持，让企业能更好地帮助退役军人就业创业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-09-04/doc-iniqskuq0832283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HBImain","MEDX","SYNB","XBI","BK4588","BK4585","GDOC","IEIH","AGNG","IBBJ","LNGR","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339358","title":"重大臨床突破引爆，康方生物單日飆漲11.45%！港股通創新藥量價齊升，新一輪行情啓動？","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339358","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339358?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 19:16","pubTimestamp":1788520560,"startTime":"0","endTime":"0","summary":"港股通创新药终于动起来了，9月4日，板块放量三连涨，100%创新药研发标的——港股通创新药ETF华宝成功收复年线外的所有均线。个股方面，康方生物单日暴涨11.45%断层领涨，成为板块情绪绝对龙头。港股通创新药板块受何驱动，新一轮行情开始启动了？文中提及个股在恒生港股通创新药精选指数中的权重占比情况见配图。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-04/doc-iniqskus1177431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","LNGR","IBBQ","LU0348784397.USD","06978","LU0348827113.USD","LU1720050803.USD","FLHK","09926","LU2778985437.USD","159992","LU0417516571.SGD","IE00BPRC5H50.USD","LU2488822045.USD","LU1794554557.SGD","LU0348783233.USD","LU2476274308.USD","IE00B543WZ88.USD","LU0348825331.USD","LU0348735423.USD","MEDX","LU0540923850.HKD","LU0417516738.SGD","LU2399975544.HKD","LU1961090484.USD","BK1574","LU0348767384.USD","LU2476274720.SGD","KURE","LU0417516902.SGD","LU0561508036.HKD","IE00B5MMRT66.SGD","LU0634319403.HKD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664233645","title":"聯邦制藥(03933.HK)：UBT251注射液完成中國超重/肥胖III期臨床研究首例試驗參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233645","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664233645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 18:55","pubTimestamp":1788519354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SYNB","XBI","IEIH","AGNG","IBBJ","LNGR","GDOC","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339848","title":"復旦張江：公司將於9月16日參加2026年半年度科創板創新藥行業集體業績説明會","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339848","media":"证券日报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339848?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 18:54","pubTimestamp":1788519240,"startTime":"0","endTime":"0","summary":"复旦张江：公司将于9月16日参加2026年半年度科创板创新药行业集体业绩说明会","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609043865545454.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609043865545454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["KSTR","159992","06978","BK1574","BK1161","MEDX","01349","BK0239","688505","IBBQ","LNGR","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664387724","title":"廣州金堃醫學檢驗實驗室有限公司成立","url":"https://stock-news.laohu8.com/highlight/detail?id=2664387724","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664387724?lang=zh_tw&edition=fundamental","pubTime":"2026-09-04 16:08","pubTimestamp":1788509280,"startTime":"0","endTime":"0","summary":"    本报讯(记者袁传玺)企查查APP显示，近日，广州金堃医学检验实验室有限公司成立，注册资本为1000万元，经营范围包含：健康咨询服务(不含诊疗服务)；第一类医疗器械 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260904/c679607419.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260904/c679607419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["MEDX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":11,"totalSize":258,"code":"91000000","status":"200"}]}}